Analyst Ratings for Avalyn Pharma (AVLN)
AVLN Rating Summary
AVLN Price Target Summary
- Highest: $80.00 (Guggenheim)
- Lowest: $52.00 (Jefferies)
- Average: $63.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$63.00 (+78.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$63.00 (+78.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | Evercore ISI | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
N/A (N/A) |
28.84 (35.28) |
22.33% | Details |
| 5/26/2026 | Morgan Stanley » Updated 8/13/2026 |
Judah Frommer | New Coverage | Overweight (N/A) |
57.00 (53.00) |
28.41 (35.28) |
24.18% | Details |
 |
||||||||
|
||||||||
